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ARTICLE
Mutations in CSPP1 Cause Primary
Cilia Abnormalities and Joubert Syndrome
with or without Jeune Asphyxiating Thoracic Dystrophy
Karina Tuz,1,21 Ruxandra Bachmann-Gagescu,2,3,21 Diana R. O’Day,4,21 Kiet Hua,1 Christine R. Isabella,4
Ian G. Phelps,4 Allan E. Stolarski,1 Brian J. O’Roak,5 Jennifer C. Dempsey,4 Charles Lourenco,6
Abdulrahman Alswaid,7 Carsten G. Bo¨nnemann,8 Livija Medne,9 Sheela Nampoothiri,10
Zornitza Stark,11 Richard J. Leventer,12 Meral Topc¸u,13 Ali Cansu,14 Sujatha Jagadeesh,15
Stephen Done,16 Gisele E. Ishak,16 Ian A. Glass,4,17 Jay Shendure,18 Stephan C.F. Neuhauss,2
Chad R. Haldeman-Englert,19 Dan Doherty,4,17,* and Russell J. Ferland1,20,*
Joubert syndrome (JBTS) is a recessive ciliopathy in which a subset of affected individuals also have the skeletal dysplasia Jeune asphyx-
iating thoracic dystrophy (JATD). Here, we have identified biallelic truncating CSPP1 (centrosome and spindle pole associated protein 1)
mutations in 19 JBTS-affected individuals, four of whom also have features of JATD. CSPP1mutations explain ~5% of JBTS in our cohort,
and despite truncating mutations in all affected individuals, the range of phenotypic severity is broad. Morpholino knockdown of cspp1
in zebrafish caused phenotypes reported in other zebrafish models of JBTS (curved body shape, pronephric cysts, and cerebellar abnor-
malities) and reduced ciliary localization of Arl13b, further supporting loss of CSPP1 function as a cause of JBTS. Fibroblasts from affected
individuals with CSPP1 mutations showed reduced numbers of primary cilia and/or short primary cilia, as well as reduced axonemal
localization of ciliary proteins ARL13B and adenylyl cyclase III. In summary, CSPP1 mutations are a major cause of the Joubert-Jeune
phenotype in humans; however, the mechanism by which these mutations lead to both JBTS and JATD remains unknown.
Introduction
Joubert syndrome (JBTS [MIM 213300]) is a recessive devel-
opmental disorder characterized by congenital hindbrain
malformations including cerebellar vermis hypoplasia,
thick superior cerebellar peduncles, a deep interpeduncular
fossa, and a variety of other brain-imaging abnormal-
ities.1–4 Individuals with JBTS have ataxia, hypotonia,
cognitive impairment, and abnormal breathing and eye
movements.1–3 In addition, subsets of individuals with
JBTS have retinal dystrophy, nephronophthisis, hepatic
fibrosis, and polydactyly. JBTS is one of an expanding
group of disorders known as ciliopathies, unified by their
overlapping clinical features and shared pathologic mech-
anisms involving the primary cilium.5 Mutations in at
least 20 genes can cause JBTS; however, the genetic cause
remains unidentified in approximately half of individuals
with JBTS.
Jeune asphyxiating thoracic dystrophy (JATD [MIM
208500]) is another autosomal-recessive ciliopathy6 and
principally affects cartilage and bone development.7–11
Individuals with JATD are characterized primarily by
having smaller and narrower rib cages, which often lead
to respiratory failure and death as a result of an inability
to fully expand the lungs.11 Affected individuals who sur-
vive often develop cystic kidney and liver disease.12
Although mutations in five genes have been shown to
cause JATD,7–10,13 details of the mechanisms underlying
JATD remain unknown.
Previously, we reported on four individuals with co-
occurring JBTS and JATD, possibly representing a geneti-
cally distinct ciliopathy phenotype.14 Here, we identify a
genetic cause of JBTS that accounts for half of our families
affected by co-occurring JATD, and we demonstrate defects
in primary cilia in cell lines from affected individuals, as
well as ciliopathy phenotypes in a zebrafish model.
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Subjects and Methods
Study Participants
Inclusion criteria for participants were (1) molar tooth sign on
brain imaging (or cerebellar vermis hypoplasia on computed-
tomography [CT] scan when MRI was not available) and (2)
clinical findings of JBTS (hypotonia, ataxia, oculomotor abnormal-
ities, cognitive impairment, and/or abnormal respiratory control).
All available MRI or CT scans of affected individuals were read by
multiple neurologists, and JBTS was diagnosed according to
accepted diagnostic criteria. Genomic DNA and/or skin biopsies
were obtained with informed consent from all participating study
subjects. The study was reviewed and approved by the institu-
tional review boards at Albany Medical College and the University
of Washington.
Exon Capture and Sequencing
Molecular inversion probes (MIPs) captured all coding exons and
10 bp of exon-flanking intronic sequence in centrosome and spin-
dle pole associated protein 1 (CSPP1 [MIM 611654, RefSeq acces-
sion number NM_024790.6]). MIP design and library preparation
were performed as described previously.15 In summary, pooled
MIPs captured CSPP1 exons from 100 ng of DNA per sample. Cap-
tures were PCR amplified with universal primers, and each reverse
primer contained a unique 8-base barcode. After amplification,
barcoded libraries were pooled and multiplex sequenced with
101-cycle, paired-end reads on the Illumina HiSeq platform.
Variant Identification
Raw sequence reads were processed and aligned to the hg19
human reference sequence (UCSCGenome Browser) with the Bur-
rows-Wheeler Aligner (BWA, version 0.5.9)16 as described.15 BAM
files were generated with Picard tools (see Web Resources), and
single-nucleotide variants (SNVs) and indels were called with the
Genome Analysis Toolkit (GATK, see Web Resources) Unified-
Genotyper,17 in which the dcov parameter was set to 5,000.
GATK was used for filtering variants according to the following
metrics: allele balance> 0.8, quality< 30, read depth< 253, qual-
ity by depth < 5, and a window of 10 for clustered variants. Vari-
ants were annotated with SeattleSeq (see Web Resources) and
further filtered against controls from the National Heart, Lung,
and Blood Institute (NHLBI) Exome Sequencing Project Exome
Variant Server (EVS) ESP6500 data set (see Web Resources) with
the use of an observed mean allele frequency threshold < 1%.
Of the variants meeting these criteria, only nonsense, nonsynon-
ymous, frameshift, and splice-site variants were considered for
further analysis. The GATK DepthOfCoverage tool was used for
determining CSPP1 sequence coverage. Positions with read depths
R 253 were considered covered. Confirmation and segregation of
identified CSPP1 variants were performed by Sanger sequencing
for all family members when DNA was available.
Zebrafish Studies
Zebrafish (Danio rerio) were maintained as previously described.18
Embryos were raised at 28C. All zebrafish protocols used in the
research described in this work were in compliance with interna-
tionally recognized guidelines for the use of fish in biomedical
research, and the experiments were approved by local authorities
(Veterina¨ramt Zu¨rich TV4206).
Morpholino oligonucleotides cspp1a ex2i2 50-ATTGAAATATAG
CCTGCCTTTGGTC-30, ex22i22 50-AGAGTTGAGTGTCAGACT
TACCTCT-30, and cspp1b ex2i2 50-TGCAAACAGAACTCTAC
CTTGCTGA-30 (Gene Tools, LLC) were injected into zebrafish
embryos at the 1- to 2-cell stage.
Whole-mount antibody staining was performed on zebrafish
embryos fixed with 4% paraformaldehyde (PFA) according to
standard protocols. Primary antibodies were rabbit polyclonal
anti-arl13b (1:100, gift from Z. Sun, Yale University)19 and mouse
monoclonal anti-acetylated a-tubulin (1:500, Sigma). Secondary
antibodies were Alexafluor goat anti-rabbit or goat anti-mouse
IgG (Life Technologies) used at 1:300. Images were acquired on a
Leica HCS LSI confocal microscope with identical settings for
morphant and control fish. Fluorescence intensities were
measured on single confocal sections with ImageJ,20 which was
blinded to injection status. In situ hybridizations on zebrafish
embryos were performed according to standard protocols. In situ
probes against cspp1a were generated with primers 50-ATTGGAGG
GACAGTTAATACAG-30 and 50-AGGAACTGGCTCGTAACC-30.
Zebrafish cartilage staining with Alcian Blue was performed
according to standard protocols.21
Cell Culture
Human dermal fibroblasts were collected from JBTS-affected indi-
viduals with CSPP1 mutations and from noncarrier siblings
through skin-punch biopsies after informed consent was
obtained. Tissue was treated with collagenase and cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 1% penicillin, and 1%
streptomycin. Once the cultures were confluent, the cells were
trypsinized (0.05% in EDTA) for 5 min at 37C, and trypsin was
subsequently inactivated with culture media containing 10%
FBS. Cell suspensions were plated on cell-culture plates or glass
coverslips (treated with 0.1% gelatin) and maintained at 37C in
a humidified atmosphere (5% CO2 and 95% air). For promoting
robust cilia formation, fibroblast cultures were starved in DMEM
containing 0.1% FBS for 48 hr.
Immunostaining and Microscopy
Human dermal fibroblasts grown on coverslips were fixed with
cold methanol (20C), 4% PFA in PBS, or 2% PFA in micro-
tubule-stabilizing buffer. Cell cultures were washed with PBS and
permeabilized with 0.04% Triton X-100 in PBS (PBS-Tx) and
blocked with 10% normal goat serum in PBS-Tx for 1 hr at room
temperature. Primary antibodies were incubated overnight at
4C and diluted in 1% normal goat serum in PBS-Tx as follows:
rabbit polyclonal anti-CSPP1, 1:200 (Proteintech); mouse
monoclonal anti-g-tubulin, 1:1,000 (Sigma); mouse monoclonal
anti-acetylated a-tubulin, 1:1,000 (Sigma); rabbit polyclonal anti-
adenylyl cyclase III (anti-AC3), 1:200 (Santa Cruz Biotechnology);
mouse monoclonal anti-Arl13b, 1:500 (UC Davis/NIH NeuroMab
Facility); and rabbit monoclonal anti-Ki-67, 1:500 (Epitomics).
Alexafluor secondary antibodies (1:500, Life Technologies) were
incubated for 1 hr at room temperature, and Hoechst DNA stain-
ing (1 mg/ml) followed. Coverslips were mounted with Fluoro-
mount-G (anti-fade) solution (Southern Biotech). Images were
obtained with a Zeiss AxioImager-Z1 microscope equipped with
an AxioCam MRm camera and processed with AxioVision Rel.
4.5 software and Adobe Photoshop CS6 (Adobe Systems). For
measuring the fluorescence-density differences of ARL13B and
AC3 in the primary cilium, all images were taken with the same
exposure time. We calculated fluorescence-density differences by
outlining each ciliary axoneme and obtaining the area of each
The American Journal of Human Genetics 94, 62–72, January 2, 2014 63
cilium and the raw integrated densities of ARL13B and AC3 immu-
nofluorescence by using these features in ImageJ.20 We calculated
fluorescence density by dividing the raw integrated densities by
the ciliary area. Importantly, this approach took into account
the area of each cilium.
Immunoblotting
Cells were lysed in Tris lysis buffer (50 mM Tris [pH 8.0], 150 mM
NaCl, 1% NP40, 1 mM DTT, 1 mM PMSF, 1 mM EDTA and a
protease inhibitor cocktail [Roche]), incubated on ice for 30 min,
and centrifuged at 10,000 3 g for 30 min at 4C. Protein samples
were separated by 8% SDS-PAGE and electroblotted onto a poly-
vinylidene fluoridemembrane. Blots were blocked with 5%nonfat
dried milk in TBS-Tx (10 mM Tris, 150 mM NaCl, 0.01% Triton
X-100, pH 7.5) for 1 hr at room temperature and incubated over-
night with anti-CSPP1 (1:200, Proteintech) at 4 C. Horseradish-
peroxidase-conjugated secondary antibodies were detected with
the SuperSignal West Femto Maximum Sensitivity Substrate
(Thermo Scientific). Chemiluminescence signals were detected
and acquired with a G:Box iChemi XT imager system and
GeneSnap software (SynGene). Images were processed with the
GeneTools software package (SynGene).
mRNA Quantification by RT-PCR
RNA from human dermal fibroblast cultures was extracted with
the Ambion RNAqueous-4PCR Kit (Life Technologies), and cDNA
was synthesized with qScript cDNA SuperMix (Quanta Biosci-
ences). PCR primers were designed against the 50 end (forward
primer 50-GTGGCCGCTGTAACCTCTT-30 and reverse primer 50-
TCAGAAAGCTTCGCTGACAA-30) and the 30 end (forward primer
50-CTGCCAGGAAAAATCAGCTC-30 and reverse primer 50-GCC
CTTAGGGGACTGTCTTC-30) of CSPP1 for amplifying ~200 bp
fragments. PCR products were separated by agarose gel electro-
phoresis and stained by ethidium bromide. The intensity of the
bands was quantified by densitometry with the GeneTools soft-
ware (SynGene).
Statistical Analyses
Two-tailed Student’s t tests were used for determining statistical
significance, except for the number of ciliated cells between
groups, for which the nonparametric Mann-Whitney U test
was employed. Statistical analyses were performed with Statistica
(StatSoft).
Results
CSPP1 Mutations Cause JBTS
A single region of copy-number-neutral absence of hetero-
zygosity was identified by a clinical SNP microarray (Affy-
metrix SNP 6.0) in chromosomal region 8q13.1–q21.12
in a male newborn (JS-1701) born to nonconsanguineous
parents and with a primary diagnosis of JBTS. The region
encompasses 40 genes present in OMIM (Table S1, avail-
able online), and Sanger sequencing identified a homozy-
gous nonsense mutation (c.2320C>T [p.Arg774*]) in
CSPP1 (Figure 1 and Table 1). This mutation is not present
in 11,906 chromosomes in the NHLBI EVS data set of 6,500
exomes (see Web Resources). To validate loss of CSPP1
function as a cause of JBTS, we sequenced all coding exons
of CSPP1 plus 10 bp of flanking intronic sequence in a
cohort of 384 affected individuals from 320 families by
using a highly efficient targeted-sequencing method.15 In-
dividuals with known genetic causes of JBTS were not
excluded from the cohort, and of note, eight affected indi-
viduals in six families had JBTS and features of JATD.
Eighteen individuals from 14 families were shown to
carry biallelic mutations in CSPP1, accounting for ~5% of
the families in our cohort (Figure 1A and Table 1). All of
the mutations are rare (<0.03%) in the NHLBI EVS data
set and are predicted to truncate the protein (nonsense,
frameshift, splice site); one such mutation of the last base
pair in exon 9 (in family UW141) results in aberrant
splicing. CSPP1 mRNA from UW141-3 fibroblasts has
10 bp inserted into the transcript, creating a stop codon
immediately downstream of the disrupted splice site
(Figure S1). When DNA samples were available from family
members, we confirmed by Sanger sequencing that the
variants segregated appropriately for autosomal-recessive
inheritance. We identified rare biallelic missense variants
in three samples; however, in two cases, the missense
variants did not segregate appropriately for autosomal-
recessive inheritance, and in the third, the affected
individual had a homozygous frameshift mutation
(c.7988_7989delGA [p.Gly2663Alafs*40]) in C5ORF42
(MIM 614571, RefSeq NM_023073.3). Three families
from Brazil (UW123, UW124, and UW148), not known
to be related, shared the same two CSPP1 mutations
(c.3211_3212insA [p.Tyr1071*] and c.2953þ1G>A
[splice]), suggesting that these families are, in fact, related.
In addition, c.2527_2528delAT (p.Met843Glufs*25) was
shared by one Lebanese and two Turkish families, indi-
cating that it is most likely a founder mutation.
Broad Phenotype in Humans
We were able to collect detailed clinical information for 18
of the 19 affected individuals, revealing a very broad spec-
trum of phenotypic severity (Table 1). The most severely
affected individuals showed profound developmental
disability (n ¼ 7), occipital encephalocele (n ¼ 1), cleft
palate (n ¼ 1), and/or skeletal features compatible with
JATD (n ¼ 3 families, 4 affected individuals; Figure 1B
and Table 1), for which two received mechanical ventila-
tion. Two siblings (UW129-3 and UW129-4) showed
evidence of liver fibrosis and chronic sinusitis without
pulmonary issues. Two other unrelated affected individ-
uals had retinal dystrophy, and another had echogenic
kidneys, but none had coloboma or polydactyly. Affected
individuals at the mild end of the spectrum had mild
developmental disability, no retinal, renal, or liver involve-
ment, and no features of JATD. We observed no obvious
correlation between the position of the truncating muta-
tions and the phenotype, and in fact, the least severely
affected individuals had the most N-terminal truncating
mutations.
The brain MRI findings in ten individuals also displayed
a wide range of severity (Table S2). In addition to the
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individual with the large occipital encephalocele, five
of ten had a posterior gap in their foramen magnum, pre-
sumably the mildest form of occipital encephalocele in
JBTS. Multiple affected individuals had cortical (three of
ten), midbrain (six of ten), and cervicomedullary (four of
ten) heterotopia. Of note, UW141-4 had a subset of the
imaging findings typically seen in individuals with JBTS
(Figures 1J–1L): mild cerebellar vermis hypoplasia
(Figure 1K) and superior cerebellar dysplasia (compare
Figure 1L to Figure 1M) without thick, misoriented
superior cerebellar peduncles (Figures 1J and 1K). Unfortu-
nately, MRI for his brother was not available for review;
however, both brothers had hypotonia, ataxia, and oculo-
motor apraxia, and UW141-3 had tachypnea as an infant,
strongly supporting a JBTS diagnosis.
cspp1 Knockdown in Zebrafish Recapitulates
Ciliopathy Phenotypes
To investigate the function of CSPP1, we examined the
effects of cspp1 knockdown in zebrafish. Zebrafish have
two putative orthologs for CSPP1, one on chromosome
Figure 1. Spectrum of Brain- and Skel-
etal-Imaging Findings in Individuals with
CSPP1-Related JBTS
(A) CSPP1 schematic showing the coiled-
coil domains (gray rectangles). Nonsense
truncating variants (blue) are indicated
above the protein at their approximate
locations. Frameshift truncating variants
(orange), variants affecting canonical
splice sites (green), and a missense variant
(a coding variant that results in a frame-
shift because of aberrant splicing; black;
see Figure S1) are indicated below the
protein. The number of times a specific
variant was identified in the cohort is indi-
cated in parentheses after the variant.
(B–E) Molar tooth sign (B), cervicomedul-
lary heterotopia (white arrow) and occipital
encephalocele (C), trident acetabulae with
inferolateral spurs (blackarrows) andmildly
short femurs (D), and amildly narrow chest
with horizontal ribs (E) in JS-1701.
(F–I) Molar tooth sign (F), cervicomedul-
lary heterotopia (white arrow) and retro-
cerebellar fluid collection (G), trident
acetabulae with inferolateral spurs (black
arrows in H), and a narrow chest with hor-
izontal ribs (I) in UW147-3.
(J–L) Normal superior cerebellar peduncles
(J), mild cerebellar vermis hypoplasia (K),
and superior cerebellar dysplasia (L) in
UW141-4.
(M) Superior vermis dysplasia in UW151-3,
who has a classic molar tooth sign (not
shown).
(B), (L), and (M) are T2-weighted images.
(C), (F), (G), (J), and (K) are T1-weighted
images.
24 (cspp1a) and a second on chromo-
some 2 (cspp1b). Given that the
conservation is higher for cspp1a
than for cspp1b, which also encodes a shorter protein, we
initially focused on cspp1a. Using in situ hybridization,
we determined that cspp1a was strongly expressed ubiqui-
tously at 24 hr postfertilization (hpf), including in the
brain and ear (Figures S2A and S2A0). At 48 hpf, expression
decreased globally but remained high in the cerebellar
fold, ear, and nose pits and became detectable in the fin
buds and somites and ventrally just above the yolk (Figures
S2B and S2C).
Two different splice morpholinos were used for knock-
ing down cspp1a function—(1) MOe2i2, targeting the
exon-intron boundary after exon 2 and expected to cause
retention of intron 2 and lead to a stop codon just after
exon 2, and (2) MOex22i22, targeting the exon-intron
boundary after exon 22—and for modeling the human
splice mutation identified in families UW123, UW124,
and UW148. The morpholinos efficiently disrupted
normal splicing in cspp1a morphants at 2 days postfertili-
zation (dpf) (Figures S2D and S2D0). Knockdown of cspp1a
with either of the morpholinos led to a curved body shape,
dilated ventricles, and pronephric cysts, a combination of
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Table 1. Clinical Phenotypes of Individuals with CSPP1-Related JBTS
Individual cDNAa Mutation (Allele)
Protein
Alteration Ethnicity Age Seizures
Abnormal
Respiratory
Pattern
Abnormal Eye
Movements Retina Kidney Ptosis Encephalocele Other
JS-1701 homozygous
c.2320C>T
homozygous
p.Arg774*
African
American
1 year N A N N N Y Y JATD, MV, hypertelorism, NG
tube, megalopapillae, optic atrophy
UW035-3 homozygous
c.2708delA (P, M)
homozygous
p.Asn903Metfs*2
Saudi
Arabian
12 years Y T nystagmus N N Y N -
UW097-3 c.2244_2245delAA (P) p.Glu750Glyfs*30 mixed
European
4 years N A or T nystagmus,
OMA
Y N Y N JATD, G-tube, third-nerve palsy
c.2280delA (M) p.Glu761Lysfs*35
UW097-6 c.2244_2245delAA (P) p.Glu750Glyfs*30 mixed
European
4 months N A or T nystagmus N Yb Y N JATD, MV, G-tube, dysphagia
c.2280delA (M) p.Glu761Lysfs*35
UW123-3 c.3211_3212insA (P) p.Tyr1071* Brazilian 10 years N A or T nystagmus N N Y N -
c.2953þ1G>A (M) splice
UW124-3 c.3211_3212insA (P) p.Tyr1071* Brazilian 14 years N A or T nystagmus N N Y N -
c.2953þ1G>A (M) splice
UW127-3 homozygous
c.2448_2454dupAGAAGAA
homozygous
p.Glu819Argfs*7
Turkish unk unk unk unk unk unk unk unk -
UW128-3 c.457delA (M) p.Arg153Glyfs*35 Chinese 2 years N T N N N Y N HL
c.2260C>T (P) p.Arg754*
UW129-3 c.658C>T (P) p.Arg220* Turkish 21 years N N N N N Y N liver fibrosis on biopsy, splenomegaly,
elevated transaminases, chronic
sinusitisc.2527_2528delAT (M) p.Met843Glufs*25
UW129-4 c.658C>T (P) p.Arg220* Turkish 16 years N N N N N Y N elevated transaminases, chronic
sinusitis
c.2527_2528delAT (M) p.Met843Glufs*25
UW130-3 homozygous
c.2527_2528delAT (P, M)
homozygous
p.Met843Glufs*25
Turkish 6 years N A or T N N N Y N cleft palate,c hypertelorism
UW137-3 c.3205þ1G>A (M) splice mixed
European
22 years N T nystagmus Y N Y N high-arched palate
c.950þ1G>C (P) splice
UW141-3 c.652C>T (M) p.Gln218* northern
European
16 years N T OMA N N N N obese
c.1214G>Ad (P) p.Arg405Glnfs*2
UW141-4 c.652C>T (M) p.Gln218* northern
European
9 years N N OMA N N N N -
c.1214G>Ad (P) p.Arg405Glnfs*2
UW143-3 c.1132C>T p.Arg378* Indian 5 years N T N N unk Y N hypertelorism, CPEO,e mild left optic
disc pallor
c.2441_2444delAGAA p.Lys814Argfs*21
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phenotypes commonly observed in zebrafish ciliopathy
gene mutants and morphants (Figures 2A–2F).19,22 Also
common in zebrafish ciliopathy models,23 abnormalities
in retinal photoreceptor outer segments were not observed
in cspp1a morphants (data not shown).
Given the observed association with skeletal defects
in individuals with CSPP1-related JBTS, we examined
whether skeletal defects were present in cspp1 morphants.
The first skeletal elements to appear in zebrafish larvae
are craniofacial cartilages at 3 dpf; these consist of a set
of ventral branchial cartilages and a more dorsal neuro-
cranium that lies just ventral to the brain.24 In both
sets of cartilages, knockdown of cspp1a consistently caused
defects that were not observed in embryos injected
with standard control morpholinos (Figures 2G–2H0).
Most prominently, the neurocranium showed patterning
defects with interruption or absence of the trabeculae,
linking the anterior-most neurocranium (ethmoid plate)
to the more posterior neurocranium (arrow and arrowhead
in Figures 2G and 2G0). On the ventral side, all of the
expected skeletal elements were present, but the anterior-
posterior length of the branchial cartilages was severely
reduced (double-headed arrow in Figures 2H and 2H0).
Knockdown of cspp1a in zebrafish did not appear to
alter the presence of cilia. Immunofluorescence staining
with anti-acetylated a-tubulin and anti-Arl13b showed
no effect on the number of cilia in cspp1a singlemorphants
or in cspp1aþcspp1b double morphants (created for
excluding the possibility of redundancy with cspp1b in
ciliogenesis), despite the presence of the above-mentioned
phenotypes, including hydrocephalus and pronephric
cysts (Figures 2I–2J0 and Figures S2E and S2E0). However,
considering the raw integrated fluorescence intensity
divided by ciliary area or the ratio of Arl13b fluorescence
to acetylated a-tubulin fluorescence for each cilium, we
did note that the intensity of Arl13b immunofluorescence
in floor-plate cilia was significantly lower in themorphants
than in the uninjected or standard-control-morpholino-
injected embryos (Figures 2I–2K; average ratio of Arl13b in-
tensity to acetylated a-tubulin intensity was 0.25 in cspp1
morphants and 1.2 in uninjected embryos, p < 0.0001).
A role for zebrafish cspp1a and/or cspp1b in ciliogenesis
cannot be entirely excluded by these experiments, given
that small amounts of residual protein might still be pre-
sent because of incomplete activity of the morpholino or
the maternal deposition of cspp1 transcript(s) and/or pro-
tein in the egg. Nevertheless, the fact that phenotypes
such as pronephric cysts or hydrocephalus were observed
in the absence of an obvious ciliogenesis defect indicates
that zebrafish cspp1a and cspp1b are most likely involved
in other aspects of ciliary function, including ciliary
Arl13b localization.
CSPP1 Is Absent from Ciliary Axonemes in Fibroblasts
from Individuals with CSPP1-Related JBTS
Previously, CSPP1 has been shown to localize to the basal
body and axoneme of primary cilia.25 In controlT
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fibroblasts, the previously validated anti-CSPP1, generated
against the N terminus (amino acids 1–208),25 labels both
the basal body and the primary cilium (marked with
g-tubulin and acetylated a-tubulin, respectively; Figures
3A and 3B). In fibroblasts from JBTS-affected individuals,
UW097-3 and UW141-3, no CSPP1 signal was present in
the axoneme, whereas the signal at the base of the cilium
remained (Figures 3A and 3B), suggesting that truncated
CSPP1 might have been present. To test whether CSPP1
nonsense-mediated decay was incomplete, we performed
RT-PCR, demonstrating that CSPP1 mRNA expression was
reduced by more than 50% in both affected fibroblast lines
(Figure S3A). On immunoblots, the N-terminal anti-CSPP1
detected full-length CSPP1 in unaffected fibroblasts, but
not in affected cells (Figure S3B); truncated CSPP1 was
below the level of detection in affected fibroblasts (data
not shown), most likely as a result of, at least in part, the
reduction in mRNA expression. Nonetheless, it is clear
that CSPP1 localization at the ciliary axoneme is absent
in affected cell lines.
Cilium Defects in Fibroblasts from Individuals with
CSPP1-Related JBTS
Given that CSPP1 localizes to primary cilia and that small
interfering RNA knockdown of CSPP1 has been shown to
decrease the number of ciliated hTERT-immortalized
retinal pigment epithelial (hTERT-RPE)25 and human-
derived retinal pigment epithelial cells (data not shown),
we evaluated whether CSPP1 mutations are associated
with cilia defects by using acetylated a-tubulin and
ARL13B immunolabeling to quantify the number and
length of primary cilia in unaffected and affected cell
lines. To induce robust cilia formation in the fibroblast
cell lines, we serum starved the cultures for 48 hr. Using
both ciliary axoneme markers, we observed a significant
reduction in cilium number in one of the affected cell
lines, UW141-3 (Figures 4A and 4C–4E); however, cilium
length was decreased in both affected fibroblast lines in
that it measured approximately half the cilium length in
control fibroblasts (Figures 4A, 4B, and 4D). To determine
whether UW141-3 fibroblasts made fewer cilia because
they were not able to enter G0, we immunostained each
of the cell lines with anti-Ki-67, a marker expressed in
cycling cells. Only a small percentage of serum-starved
cells (6%–10%) expressed Ki-67, and no differences were
noted between unaffected and affected cells (Figures S4A
and S4B).
Many of the proteins implicated in JBTS function at the
transition zone of the proximal cilium to regulate protein
traffic in and out of the cilium.26–30 Given that loss of
Figure 2. Ciliopathy Phenotypes in cspp1 Zebrafish Morphants
(A–F) Morpholino knockdown of cspp1a resulted in a curved body
shape (B) and dilated brain ventricles (double-headed arrows in B
and D) associated with an increased gap between the two sides of
the tectum (asterisk in D) and a thin cerebellar fold (arrowhead in
D, compared to arrowhead in C). Pronephric cysts were observed
in cspp1a morphants (white arrows in B and F), as highlighted in
the wt1b-GFP transgenic line (E versus F).
(G–H0) Knockdown of cspp1a also led to abnormal development of
head cartilages, affecting both the neurocranium (G and G’) and
the branchial cartilages (H andH0). Observed phenotypes included
interruption (arrowhead in G’) or loss (arrow in G0) of trabeculae
and shortened distance between the branchial cartilages (double
arrow in H’). The wild-type is shown in (H) for comparison.
(I and J) Immunolabeling of floor-plate cilia in 48 hpf uninjected
(I) and cspp1aþcspp1b double-morpholino-injected embryos (J)
with anti-Arl13b (green) and anti-acetylated a-tubulin (red) shows
decreased Arl13b fluorescence (arrows in I0 and J0).
(K) The ratio of Arl13b fluorescence to acetylated a-tubulin fluores-
cence was significantly lower in cspp1aþcspp1b double morphants
than in uninjected embryos (p < 0.0001, n ¼ 20 morphants and
15 uninjected embryos). Results are expressed as themean5 SEM.
Abbreviations are as follows: p, pancreas; g, glomerulus; T, tectum;
t, trabeculae; and ep, ethmoid plate. The anterior is to the left in all
panels. Embryo ages are 48 hpf (A–D), 3 dpf (E and F), 6 dpf (G and
H), and 48 hpf (I and J). Scale bars represent 10 mm (I and J) and
5 mm (I0 and J0).
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JBTS-associated gene function has been shown to result in
reduced axonemal localization of ciliary proteins, such as
ARL13B and AC3,26,31 and that our results show that
cspp1 knockdown in zebrafish leads to decreased ciliary
localization of Arl13b, we examined the levels of ARL13B
and AC3 in primary cilia of control and UW097-3 (with
normal numbers of primary cilia) cell lines by measuring
raw integrated fluorescence intensity divided by ciliary
area. Although most cilia were positive for ARL13B in the
UW097-3 cell line (Figures 4D and 4E), we found that the
amount of axonemal ARL13B was 20% less than that of
the control (p< 0.0001; Figures 4D and 4F). A similar effect
was seen in the UW141-3 cell line, which had fewer cilia
(Figure 4D).
AC3 localized to the primary cilium at similar per-
centages in both control and UW097-3 cell lines (Figures
5A and 5B). However, in the UW141-3 cell line, only
Figure 3. CSPP1 Is Not Localized in the
Primary Cilia Axoneme of Dermal Fibro-
blasts from Individuals with CSPP1-
Related JBTS
(A) CSPP1 localized to the centrioles in
dermal fibroblasts from individuals with
CSPP1-related JBTS (UW097-3 and
UW141-3) and controls. Fibroblasts were
immunostained with anti-CSPP1 (red)
and antibodies to the basal body marker
g-tubulin (green). The arrowheads point
at the colocalization of both proteins.
The arrow marks the localization of
CSPP1 in the ciliary axoneme only in con-
trol cells. DNA was visualized with
Hoechst 33258 (blue). Scale bars represent
2 mm.
(B) CSPP1 signal was absent from
the axoneme of the primary cilium but
remained at the basal body in affected
fibroblasts. Serum-starved affected and
control fibroblasts were immunostained
with anti-CSPP1 (red) and antibodies
to the ciliary axoneme marker acetylated
a-tubulin (green). The arrowheads
mark the location of acetylated-a-tubulin-
positive cilia. Note the absence of CSPP1
in the ciliary axoneme of affected
fibroblasts. DNA was visualized with
Hoechst 33258 (blue). Scale bars represent
5 mm.
39% of the remaining cilia were
AC3 positive (Figures 5A and 5B).
Furthermore, in the UW097-3 cell
line, the amount of AC3 signal in
the axoneme was 48% lower than
that in the control (p < 0.0001; Fig-
ures 5A and 5C).
Discussion
We have shown that loss of CSPP1
function causes ~5% of JBTS in
humans and results in ciliopathy phenotypes in zebrafish.
The spectrum of CSPP1-related human phenotypes is
broad, including two brothers with typical clinical features
of JBTS (hypotonia, ataxia, oculomotor apraxia, and
mild cognitive dysfunction), but only a subset of the
characteristic imaging features. Moreover, mutations in
CSPP1 are a major cause of the previously reported co-
occurrence of JBTS and JATD,14 explaining three of
the six families affected by this phenotype in our cohort.
On the basis of the currently available human data,
CSPP1 mutations are not highly associated with retinal,
kidney, or liver involvement in humans, although these
features do occur. Similar to loss of CSPP1 function in
humans, loss of cspp1 function in zebrafish affects skeletal
development and results in pronephric cysts (analogous
to human cystic kidney disease). Lastly, loss of CSPP1
function in humans appears to affect primary cilium
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formation, length, and trafficking of ciliary proteins to
the axoneme.
The decreased cilium number and length in cell lines
with CSPP1 mutations are similar to the effects seen with
loss-of-function mutations in several other genes involved
in JBTS.32,33 In addition, prior work has shown that CSPP1
overexpression in hTERT-RPE cells results in longer cilia.25
These observations, in combination with our own, suggest
that CSPP1might be involved in the control of cilia length.
Although it is not possible to draw a genotype-phenotype
conclusion on the basis of two cell lines, the cell line with
the more N-terminal truncating mutations (UW141-3) has
both reduced cilium number and length, whereas the line
with more C-terminal truncating mutations (UW097-3)
only has reduced cilium length.
The majority of proteins involved in the pathogenesis
of JBTS localize to the basal body or transition zone
of the primary cilium, where they form functional
complexes. The transition zone controls the transport of
proteins such as AC3 and ARL13B in and out of the pri-
mary cilium28,34 through the tectonic and NPHP com-
plexes.26,30 Similarly, we have shown that CSPP1 is
required for localization of AC3 and ARL13B to the pri-
mary cilium. Patzke et al. demonstrated that CSPP1 binds
RPGRIP1L (NPHP8) and NPHP4 in a complex,25 providing
additional evidence that CSPP1 functions at the transition
zone. However, CSPP1 also localizes to the ciliary
axoneme, so it could function there as well.
In conclusion, our results demonstrate that mutations
in CSPP1 cause JBTS, including the JBTS-JATD ciliopathy
phenotype. Although CSPP1 is required for localization
of axonemal proteins, such as ARL13B and AC3, how loss
of CSPP1 function leads to both JBTS and JATD remains
unknown. Given the prominent role of intraflagellar trans-
port (IFT) in the mechanisms underlying JATD, CSPP1
might participate in the IFT-dependent localization of
axonemal proteins required for skeletal development.
Future work will focus on identifying additional com-
ponents of the functional networks underlying JBTS and
JATD, as well as understanding how genetic perturbations
result in the broad spectrum of phenotypes seen in individ-
uals with JBTS.
Figure 4. Dermal Fibroblasts from Indi-
viduals with CSPP1-Related JBTS Muta-
tions Have Short Cilia and Abnormal
Ciliary ARL13B Localization
(A) Primary cilia on affected and control
fibroblasts immunostained for acetylated
a-tubulin. Arrowheads point to primary
cilia. DNA was stained with Hoechst
33258 (blue). Scale bars represent 5 mm.
(B) Fibroblasts from individuals with
CSPP1-related JBTS had shorter primary
cilia. Dermal fibroblasts were immuno-
stained with anti-acetylated a-tubulin,
and cilia lengths were measured with
AxioVision software. Results are expressed
as the mean5 SEM. *p < 0.0001.
(C) UW141-3 fibroblasts had fewer cilia.
For quantifying cilia, the number of cells
with acetylated-a-tubulin positive cilia
were counted (>100 cells per coverslip).
Results are expressed as the mean 5 SEM
(n ¼ 3). *p < 0.01.
(D) Fibroblast cell lines immunostained
with anti-ARL13B and Hoechst 33258. Ar-
rowheads point at primary cilia. Scale bars
represent 5 mm.
(E) ARL13B localized to the primary cilium
in unaffected and affected fibroblasts; the
UW141-3 cell line had fewer ARL13B-
positive cilia. The number of cells with
ARL13B immunolabeling at primary cilia
was counted in 300 cells per cell line. Re-
sults are expressed as the mean 5 SEM. *
p < 0.001.
(F) The ciliary distribution of ARL13B was
reduced in affected fibroblasts. Images of
ARL13B immunolabeling in control and
affected cells were taken with the same set-
tings, and fluorescence density of ARL13B
immunostaining at the primary cilium
was quantified in >20 cells with ImageJ.
Results are expressed as the mean 5
SEM. *p < 0.0001.
70 The American Journal of Human Genetics 94, 62–72, January 2, 2014
Supplemental Data
Supplemental Data include four figures and two tables and can be
found with this article online at http://www.cell.com/AJHG.
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